Medicine and Dentistry
Breast Cancer
100%
Malignant Neoplasm
94%
Disease
81%
Asthma
73%
Neoplasm
55%
Women's Health
47%
Oncology
45%
Wheeze
41%
Hazard Ratio
37%
Prostate Cancer
36%
Physical Activity
36%
Postmenopause
35%
Symptom
33%
Nodular Melanoma
32%
Biological Marker
31%
Clinical Trial
30%
Obstructive Sleep Apnea
28%
Colorectal Cancer
28%
Placebo
26%
Cancer Risk
26%
Radiation Therapy
26%
Cardiovascular Disease
26%
Overall Survival
24%
Body Mass Index
24%
Odds Ratio
23%
Metastatic Carcinoma
22%
Non Small Cell Lung Cancer
22%
Chronic Obstructive Pulmonary Disease
20%
COVID-19
20%
Childbirth
18%
Cardiovascular System
18%
Pediatrics
18%
Prostate Carcinoma
17%
Doxorubicin
17%
Heart Failure
17%
Cyclophosphamide
17%
Cancer Prevention
16%
Quality of Life
16%
Tumor Cell
16%
Recurrent Disease
16%
Infection
15%
Systematic Review
15%
In Vitro
15%
Sleep Time
15%
Randomized Controlled Trial
15%
Small Cell Lung Cancer
15%
Cancer Mortality
14%
Gene Expression
14%
Dietary Pattern
14%
Magnetic Resonance Imaging
14%
Cisplatin
13%
Diagnosis
13%
Prevalence
13%
Ovarian Cancer
13%
Myocardial Infarction
13%
Colon Cancer
13%
Sleep Disorder
13%
Respiratory Disease
13%
Surgery
13%
Diabetes
13%
Proportional Hazards Model
13%
Lung Transplantation
12%
Adenoma
12%
Adjuvant Therapy
12%
Acute Myeloid Leukemia
12%
Cohort Analysis
12%
Drug Therapy
11%
Obesity
11%
Metastatic Breast Cancer
11%
Biopsy
11%
Disease Free Survival
11%
Colorectal Adenoma
11%
Arm
11%
Cancer Therapy
11%
Phase II Trials
11%
Sleep Medicine
11%
Positive Airway Pressure
11%
Bone Marrow Transplantation
11%
Prostate Specific Antigen
10%
Integrin
10%
Etoposide
10%
Diet Therapy
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Metastatic Melanoma
10%
Epithelial Cell
10%
Tamoxifen
10%
Health Care Cost
10%
Rectum Cancer
9%
Acute Respiratory Distress Syndrome
9%
Public Health
9%
Metabolic Syndrome
9%
Observational Study
9%
Protein P53
9%
Clinician
9%
Heart Failure with Preserved Ejection Fraction
9%
Nonalcoholic Fatty Liver
9%
Lymphocyte
9%
Bone Metastasis
9%
Drug Megadose
8%
Cancer
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
96%
Asthma
87%
Breast Cancer
75%
Malignant Neoplasm
66%
Neoplasm
62%
Mouse
56%
Chemotherapy
56%
Nonalcoholic Fatty Liver
42%
Cyclophosphamide
41%
Placebo
41%
Doxorubicin
39%
Melanoma
36%
Prostate Cancer
35%
Cisplatin
32%
Wheezing
31%
Clinical Trial
31%
Symptom
30%
Sleep Disordered Breathing
29%
Biological Marker
28%
Heart Failure
27%
Pharmacokinetics
25%
Overall Survival
24%
Non Small Cell Lung Cancer
23%
Phase II Trials
21%
Heart Infarction
19%
Prostate Carcinoma
18%
Heart Failure with Preserved Ejection Fraction
18%
Chronic Obstructive Lung Disease
18%
Lung Cancer
18%
Metastatic Breast Cancer
17%
Small Cell Lung Cancer
17%
Remission
17%
Etoposide
17%
Colorectal Cancer
16%
Infection
16%
Prevalence
15%
Nanoparticle
15%
Cardiovascular Disease
15%
Inflammation
15%
Progression Free Survival
15%
Colon Cancer
14%
Disease Free Survival
14%
Imexon
14%
Recurrent Disease
14%
Paclitaxel
13%
Immunotherapy
13%
Solid Malignant Neoplasm
13%
Dry Powder Inhaler
13%
Prostate Specific Antigen
13%
Cohort Study
12%
Cytotoxicity
12%
Adult Respiratory Distress Syndrome
11%
Metastatic Melanoma
11%
Xenobiotic Agent
11%
Anticarcinogen
11%
Adverse Event
10%
Acute Heart Infarction
10%
Sleep Disorder
10%
Obesity
10%
Colorectal Adenoma
10%
Elimination
10%
Bile Acid
10%
Tumor Necrosis Factor
10%
Spironolactone
9%
Tamoxifen
9%
Vincristine
9%
Mitomycin
9%
Myeloma
9%
Acute Myeloid Leukemia
9%
Survival Rate
9%
Coronavirinae
9%
Methionine
9%
Pancreas Cancer
9%
Metastasis
9%
Choline
8%
Vitamin D
8%
Fluorouracil
8%
Pulmonary Hypertension
8%
Dacarbazine
8%
Denosumab
8%
Integrin
8%
Randomized Clinical Trial
8%
Bone Metastasis
8%
Cancer Mortality
8%
Receptor
8%
Glutathione
8%
Disease Exacerbation
8%
Mouse Model
8%
Adverse Drug Reaction
8%
Respiratory Tract
8%
Observational Study
8%
SARS Coronavirus
8%
Microparticle
8%
Drug Resistance
8%
Matrilysin
8%
Cell Culture
8%
Mycobacterium Bovis BCG
7%
Effusion
7%
Epileptic Absence
7%
Fluticasone
7%
Keyphrases
Asthma
73%
Women's Health Initiative
46%
Confidence Interval
45%
Breast Cancer
42%
Southwest Oncology Group
35%
Wheezing
32%
Postmenopausal Women
32%
Physical Activity
29%
Hazard Ratio
28%
Insomnia
27%
Chemotherapy
24%
Group Studies
23%
Risk Factors
23%
Body Mass Index
22%
Obesity
21%
Tumor
21%
Sleep Health
20%
Prostate Cancer
20%
Odds Ratio
19%
Obstructive Sleep Apnea
18%
Sleep Duration
18%
Lung Function
18%
Cisplatin
18%
Colorectal Cancer
18%
Cyclophosphamide
17%
Melanoma
17%
Phase II Trial
16%
In Cancer
16%
Clinical Trials
16%
Nonalcoholic Steatohepatitis
16%
Randomized Trial
16%
Placebo
15%
COVID-19
15%
United States
15%
Imexon
15%
Lymphocytes
14%
Inhaled Corticosteroids
14%
Hispanic
14%
Colorectal Adenoma
13%
Heart Failure with Preserved Ejection Fraction (HFpEF)
13%
Liver
13%
Childhood Asthma
12%
Tumor Necrosis Factor-α
12%
Sleep Disorders
12%
Human Prostate
12%
Metastatic Breast Cancer
12%
Lower Respiratory Tract Infection
12%
Tumor Cells
12%
Dietary Intervention
12%
Tucson
12%
Older Adults
11%
Cardiovascular Disease
11%
Excessive Daytime Sleepiness
11%
Cancer Survivors
11%
Doxorubicin
11%
Forced Expiratory Volume in 1 Second (FEV1)
11%
Overall Survival
11%
Randomized Controlled Trial
10%
Heart Failure
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Integrin
10%
Early Breast Cancer
10%
Phase II Study
10%
Lung Transplantation
10%
Breast Cancer Survivors
10%
Weight Loss
10%
Genome-wide Association Study
10%
Sleep Quality
10%
Colon Cancer
9%
Cancer Patients
9%
Interferon-α (IFN-α)
9%
Arizona
9%
African American
9%
Response Rate
9%
Sleep Disturbance
9%
Allogeneic Bone Marrow Transplantation
9%
High Risk
9%
Dietary Modification
9%
Etoposide
9%
Mental Health
9%
Lung
9%
Prostate Carcinoma
9%
Prostate-specific Antigen
9%
Non-Hispanic White
9%
Acute Myocardial Infarction
8%
Mouse Model
8%
Cystic Fibrosis
8%
Metastasis
8%
Non-alcoholic Fatty Liver Disease (NAFLD)
8%
Immune Response
8%
Early childhood
8%
Remission
8%
Quality of Life
8%
Poor Sleep
8%
Cancer Prevention
8%
First Year of Life
8%
Protein Expression
8%
Chronic Obstructive Pulmonary Disease
8%
AIDS/HIV
8%
Race-ethnicity
8%